Cargando…
Vortioxetine Treatment Reverses Subchronic PCP Treatment-Induced Cognitive Impairments: A Potential Role for Serotonin Receptor-Mediated Regulation of GABA Neurotransmission
Major depressive disorder (MDD) is associated with cognitive impairments that may contribute to poor functional outcomes. Clinical data suggests that the multimodal antidepressant vortioxetine attenuates some cognitive impairments in MDD patients, but the mechanistic basis for these improvements is...
Autores principales: | Pehrson, Alan L., Pedersen, Christian S., Tølbøl, Kirstine Sloth, Sanchez, Connie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5845537/ https://www.ncbi.nlm.nih.gov/pubmed/29559911 http://dx.doi.org/10.3389/fphar.2018.00162 |
Ejemplares similares
-
Impact of Vortioxetine on Synaptic Integration in Prefrontal-Subcortical Circuits: Comparisons with Escitalopram
por: Chakroborty, Shreaya, et al.
Publicado: (2017) -
Vortioxetine restores reversal learning impaired by 5-HT depletion or chronic intermittent cold stress in rats
por: Wallace, Ashley, et al.
Publicado: (2014) -
Vortioxetine Improves Context Discrimination in Mice Through a Neurogenesis Independent Mechanism
por: Felice, Daniela, et al.
Publicado: (2018) -
Vortioxetine Differentially Modulates MK-801-Induced Changes in Visual Signal Detection Task Performance and Locomotor Activity
por: Hillhouse, Todd M., et al.
Publicado: (2018) -
Effects of Subchronic Administrations of Vortioxetine, Lurasidone, and Escitalopram on Thalamocortical Glutamatergic Transmission Associated with Serotonin 5-HT7 Receptor
por: Okada, Motohiro, et al.
Publicado: (2021)